Judicious antibiotic use and intranasal corticosteroids in acute rhinosinusitis

Catherine Butkus Small1, Claus Bachert, Valerie J Lund

  • 1Division of Infectious Diseases, Department of Medicine, New York Medical College, Westchester Medical Center, Valhalla 10595, USA. Catherine_Small@nymc.edu

Insights

Intranasal corticosteroids offer a safe alternative for treating acute rhinosinusitis, particularly viral infections. This approach can reduce unnecessary antibiotic use and combat growing antibiotic resistance.

Area of Science:

  • Otolaryngology
  • Infectious Diseases
  • Pharmacology

Background:

  • Acute rhinosinusitis is frequently treated with antibiotics, despite many cases stemming from viral infections.
  • Overuse of antibiotics for nonbacterial rhinosinusitis fuels antibiotic resistance.
  • Effective, non-antibiotic treatments are crucial for managing viral acute rhinosinusitis.

Purpose of the Study:

  • To evaluate intranasal corticosteroids as an alternative to antibiotics for acute rhinosinusitis.
  • To assess the efficacy of intranasal corticosteroids in reducing antibiotic use.

Main Methods:

  • Review of controlled trials investigating intranasal corticosteroids for acute rhinosinusitis.
  • Analysis of symptom relief and resolution rates in treated patients.

Main Results:

  • Intranasal corticosteroids demonstrated significant symptom relief in acute rhinosinusitis.
  • These agents were effective both as monotherapy and in combination with antibiotics.
  • Potential to reduce inappropriate antibiotic prescriptions.

Conclusions:

  • Intranasal corticosteroids are a viable and effective treatment for acute rhinosinusitis.
  • Their use may decrease reliance on antibiotics, thereby mitigating antibiotic resistance.
  • Consideration of intranasal corticosteroids can improve patient outcomes and public health.

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: